The US Food and Drug Administration has approved a landmark eye drop that uses a combined dose of medication to restore ...
Morning Overview on MSN
FDA clears 1st dual-action eye drop to fight age-related vision loss
Age-related near vision loss has long been treated as an inevitable annoyance of getting older, a slow erosion of clarity ...
If you are over forty, you know the feeling. It starts subtly — a menu held just a little further away at dinner, or the ...
MedPage Today on MSN
FDA OKs More Eye Drops That Can Replace Reading Glasses
Once-daily carbachol/brimonidine tartrate significantly improves aging-related vision loss ...
The burden of presbyopia and reading glasses drives patients to look for solutions.“There is a clear and growing patient ...
The FDA has approved the first dual-agent eye drop to treat presbyopia, a condition that causes gradual loss of near vision in adults.
The U.S. Food and Drug Administration has approved Yuvezzi (carbachol and brimonidine tartrate) ophthalmic solution 2.75%/0.1 ...
Combining two eye drops that have been on the market for at least 30 years each has earned Tenpoint Therapeutics an FDA ...
The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
The biotech also raised $235 million in debt and equity funding to support marketing of the drop, which it claims to be an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results